Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Fusidic Acid I.P. 2.00% w/w + Beclomethasone Dipropionate I.P. 0.025% w/w
Therapeutic Category
Antibiotic, Anti-Inflammatories, Dermatology
Dosage Form
Cream
Packaging Type
Pack
Packaging
10gm
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Fusidic Acid I.P. (2.00% w/w) and Beclomethasone Dipropionate I.P. (0.025% w/w). It is an effective combination of an antibiotic and a corticosteroid, specifically designed to treat bacterial skin infections associated with inflammation, redness, and itching.
Fusidic Acid is a potent antibiotic that works by inhibiting bacterial protein synthesis, effectively eliminating bacteria responsible for skin infections. Beclomethasone Dipropionate, a corticosteroid, helps in reducing inflammation, redness, and itching, providing relief from discomfort and preventing further irritation.
This combination is particularly beneficial in treating infected eczema, dermatitis, impetigo, and other bacterial skin conditions where inflammation and bacterial growth coexist.
Rarely causes skin irritation, redness, or allergic reactions in sensitive individuals. Discontinue use if irritation occurs.
Used for covering and protecting minor cuts, wounds, scrapes, and blisters to prevent contamination and support healing.
For external use only. Do not apply on deep wounds, infected cuts, or burns. Replace the bandage regularly to maintain hygiene.
Store in a cool, dry place, away from direct sunlight and moisture. Keep in the original packaging to maintain sterility.
Composition : Fusidic Acid 2% Cream
Composition : Ciprofloxacin HCL I.P. 1% w/w + Metronidazole I.P. 1% w/w + Terbinafine HCL I.P. 1% w/w + Clobetasol Propionate I.P. 0.05% w/w Cream
Composition : Ofloxacin I.P. 0.75% w/w + Ornidazole I.P. 2.0% w/w + Itraconazole B.P. 1.0% w/w + Clobetasol Propionate I.P. 0.05% w/w + Methylparaben I.P. 0.2% w/w + Propylparaben I.P. 0.02% w/w Cream
Composition : Metronidazole (1% w/w) + Sucralfate (7% w/w) + Povidone Iodine (5% w/w)
Composition : Clobetasole 0.05% + Neomycin 0.5% + Miconazole 2%
Composition : Beclomethasone 0.025% +Clotrimazole 1% +Neomycin 0.5% +Chlorocresol 0.1% Cream
Composition : Beclometasone (0.025% w/v) + Clotrimazole (1% w/v) lotion
Composition : Clotrimazole (1% w/w) Dusting Powder
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination has strong demand in the dermatology and anti-infective skin-care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on skin infection, allergy, and inflammation management portfolios.
Medical distributors and agencies can benefit from consistent demand for management of infected eczema, dermatitis, fungal-bacterial mixed skin infections, itching, redness, and inflamed skin conditions. Fusidic Acid is a topical antibiotic effective against bacterial skin infections Beclomethasone Dipropionate 0.025% is a corticosteroid that reduces inflammation, redness, and itching This combination strengthens a reliable dermatology and skin-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Fusidic Acid + Beclomethasone Dipropionate Cream with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong dermatologist prescriptions, high demand in mixed skin infections, fast-moving dermatology sales, reliable supply chain support, and good margins in skin-care products.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.